Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
medgepeptides.com
Samples
Passed
Failed
Trust score updated: May 29, 2026 · 100% pass rate
Composite score based on 27 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Tesofensine | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot 25E 019 · Report 2601120229 |
| Jan 12, 2026 | SLU-PP-332 | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot 25F 023 · Report 2601120227 |
| Jan 12, 2026 | Epitalon | HPLC purity | PASS | 99.374% | Freedom Diagnostics |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 27 COAs attributed to this vendor. Last recomputed 2026-05-29.
PMB address (-0.03), New domain (-0.06), No phone number (-0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot EPI50A 11 14 25 · Report 2601120206 |
| Jan 12, 2026 | Hexarelin | HPLC purity | PASS | 99.707% | Freedom Diagnostics | Lot HEXSLT12 · Report 2601120207 |
| Jan 12, 2026 | Semax | HPLC purity | PASS | 99.19% | Freedom Diagnostics | Lot SMX30A 12 29 25 · Report 2601120211 |
| Jan 12, 2026 | NAD+ | HPLC purity | PASS | 99.797% | Freedom Diagnostics | Lot FNAD100MN 12 22 25 · Report 2601120222 |
| Jan 12, 2026 | Epitalon | HPLC purity | PASS | 99.374% | Freedom Diagnostics | Lot EPI50A T1 14 25 · Report 2601120206 |
| Jan 12, 2026 | LL-37 | HPLC purity | PASS | 99.703% | Freedom Diagnostics | Lot LL375LT12 · Report 2601120208 |
| Jan 12, 2026 | Ipamorelin | HPLC purity | PASS | 99.804% | Freedom Diagnostics | Lot IPA10N 08 19 25 · Report 2601120217 |
| Jan 12, 2026 | CJC-1295 (NO DAC) | HPLC purity | PASS | 99.884% | Freedom Diagnostics | Lot CND10N 07 26 2S · Report 2601120216 |
| Jan 12, 2026 | BPC-157 | HPLC purity | PASS | 99.614% | Freedom Diagnostics | Lot BPCTB410 11 24 25-01 · Report 2601120209 |
| Jan 12, 2026 | GHK-Cu | HPLC purity | PASS | 99.767% | Freedom Diagnostics | Lot GHK50N 10 16 25 · Report 2601120218 |
| Jan 12, 2026 | CJC-1295 (NO DAC) | HPLC purity | PASS | 99.884% | Freedom Diagnostics | Lot CND10N 07 26 25 · Report 2601120216 |
| Jan 12, 2026 | Hexarelin | HPLC purity | PASS | 99.707% | Freedom Diagnostics | Lot HEX5LT12 · Report 2601120207 |
| Jan 12, 2026 | Tesofensine | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot 25F 019 · Report 2601120228 |
| Jan 12, 2026 | MOTS-C | HPLC purity | PASS | 99.592% | Freedom Diagnostics | Lot MOTS 11 19 25 J · Report 2601120215 |
| Jan 12, 2026 | BPC-157 | HPLC purity | PASS | 99.614% | Freedom Diagnostics | Lot BPCTB410 II 24 25-01 · Report 2601120209 |
| Jan 12, 2026 | NAD+ | HPLC purity | PASS | 99.797% | Freedom Diagnostics | Lot FNAD1000N 12 22 25 · Report 2601120222 |
| Jan 12, 2026 | SLU-PP-332 | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot 25G 028 · Report 2601120226 |
| Jan 12, 2026 | GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.886% | Freedom Diagnostics | Lot KL80-T12 · Report 2601120224 |
| Jan 12, 2026 | Klow | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot KL80LT12 · Report 2601120225 |
| Jan 12, 2026 | GHK-Cu | HPLC purity | PASS | 99.767% | Freedom Diagnostics | Lot GHKS0N 10 16 25 · Report 2601120218 |
| Jan 12, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99.743% | Freedom Diagnostics | Lot TAL10LT12 · Report 2601120205 |
| Jan 12, 2026 | Ipamorelin/Tesamorelin | HPLC purity | PASS | 99.213% | Freedom Diagnostics | Lot 2X-12N 12 18 25 · Report 2601120214 |
| Jan 12, 2026 | 5-Amino-1MQ | Identity & safety panels | PASS | -- | Freedom Diagnostics | Lot 25L 040 · Report 2601120230 |
| Jun 4, 2026 | GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.886% | Freedom Diagnostics | Lot KL80LT12 · Report 2601120224 |
| Jun 4, 2026 | BPC-157 | HPLC purity | PASS | 99.215% | Freedom Diagnostics | Lot BPC20N 10 09 25 · Report 2601120212 |